Hepatitis A Vaccines
Inactivated viral vaccines
This page catalogs 4 standalone hepatitis A vaccine products. Hepatitis A vaccines use inactivated viral technology and are recommended for all children at age 1 year, travelers to endemic areas, and other at-risk groups.
Note: A combination hepatitis A/B vaccine (Twinrix) is also available. See the Combination Vaccines catalog.
Last updated: April 2026.
Hepatitis A Vaccine Catalog
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| Havrix | Hepatitis A vaccine, inactivated | GSK | Inactivated viral | FDA Licensed, 1995 | Pediatric and adult formulations |
| Vaqta | Hepatitis A vaccine, inactivated | Merck | Inactivated viral | FDA Licensed, 1996 | Pediatric and adult formulations |
| Avaxim | Hepatitis A vaccine, inactivated | Sanofi Pasteur | Inactivated viral | Licensed (non-US) | Sanofi product; not US-licensed |
| Epaxal | Hepatitis A vaccine, virosomal | Crucell/Janssen | Virosomal | Licensed (non-US); Discontinued | Virosomal formulation; discontinued |
Sources
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026) and EMA Medicines database. Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.